Global Ocular Drug Delivery Technology Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Ocular Drug Delivery Technology Market Insights, Forecast to 2034
Ocular administration of drug isprimarily associated with the need totreat ophthalmic diseases.
Market Analysis and InsightsGlobal Ocular Drug Delivery Technology Market
Global Ocular Drug Delivery Technology market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Ocular Drug Delivery Technology industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Ocular Drug Delivery Technology key companies include OCULAR THERAPEUTIX, Alimera Sciences, EyeGate Pharma, Bausch Health, Envisia Therapeutics, Clearside Biomedical, Graybug Vision and Taiwan Liposome Company, etc. OCULAR THERAPEUTIX, Alimera Sciences, EyeGate Pharma are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Ocular Drug Delivery Technology were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the share will be % in 2029. Moreover, China, plays a key role in the whole Ocular Drug Delivery Technology market and estimated to attract more attentions from industry insiders and investors.
Ocular Drug Delivery Technology can be divided into Topical, Ocular Inserts, Iontophoresis and Intraocular Implants, etc. Topical is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2029.
Ocular Drug Delivery Technology is widely used in various fields, such as Hospitals, Ambulatory Surgical Centers and Clinics,, etc. Hospitals provides greatest supports to the Ocular Drug Delivery Technology industry development. In 2022, global % revenue of Ocular Drug Delivery Technology went into Hospitals filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Ocular Drug Delivery Technology market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Ocular Drug Delivery Technology market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
OCULAR THERAPEUTIX
Alimera Sciences
EyeGate Pharma
Bausch Health
Envisia Therapeutics
Clearside Biomedical
Graybug Vision
Taiwan Liposome Company
Segment by Type
Topical
Ocular Inserts
Iontophoresis
Intraocular Implants
Hospitals
Ambulatory Surgical Centers
Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Ocular Drug Delivery Technology introduction, etc. Ocular Drug Delivery Technology Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports’s Conclusions of Ocular Drug Delivery Technology
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports
Market Analysis and InsightsGlobal Ocular Drug Delivery Technology Market
Global Ocular Drug Delivery Technology market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Ocular Drug Delivery Technology industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Ocular Drug Delivery Technology key companies include OCULAR THERAPEUTIX, Alimera Sciences, EyeGate Pharma, Bausch Health, Envisia Therapeutics, Clearside Biomedical, Graybug Vision and Taiwan Liposome Company, etc. OCULAR THERAPEUTIX, Alimera Sciences, EyeGate Pharma are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Ocular Drug Delivery Technology were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the share will be % in 2029. Moreover, China, plays a key role in the whole Ocular Drug Delivery Technology market and estimated to attract more attentions from industry insiders and investors.
Ocular Drug Delivery Technology can be divided into Topical, Ocular Inserts, Iontophoresis and Intraocular Implants, etc. Topical is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2029.
Ocular Drug Delivery Technology is widely used in various fields, such as Hospitals, Ambulatory Surgical Centers and Clinics,, etc. Hospitals provides greatest supports to the Ocular Drug Delivery Technology industry development. In 2022, global % revenue of Ocular Drug Delivery Technology went into Hospitals filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Ocular Drug Delivery Technology market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Ocular Drug Delivery Technology market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
OCULAR THERAPEUTIX
Alimera Sciences
EyeGate Pharma
Bausch Health
Envisia Therapeutics
Clearside Biomedical
Graybug Vision
Taiwan Liposome Company
Segment by Type
Topical
Ocular Inserts
Iontophoresis
Intraocular Implants
Segment by Application
Hospitals
Ambulatory Surgical Centers
Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Ocular Drug Delivery Technology introduction, etc. Ocular Drug Delivery Technology Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports’s Conclusions of Ocular Drug Delivery Technology
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices